On November 28, 2024, the "Gathering for Regenerative Medicine Connecting to the Future," themed around the future of medicine and science, was held. This event attracted considerable attention as a forum where leading experts and medical professionals in the field of regenerative medicine gathered to share the latest technologies and research results. The organizer, Well Medical Group Co., Ltd., develops advanced medical services centered on regenerative medicine, and this event was planned as a platform to widely share its philosophy.
Shiho Hashimoto
Born in Fukuoka Prefecture in 1967. Due to her small stature, lack of athletic ability, and frail constitution, she began track and field in the fourth grade of elementary school under the strict guidance of her father. During her school years, she belonged to the track and field club, and while in junior high school, high school, and university, she competed in national championships as a prefectural and Kyushu representative in ekiden (long-distance relay races). After graduating from the Faculty of Physical Education at Fukuoka University, she joined FBS Fukuoka Broadcasting. She worked in the news department as a reporter and announcer. During her four years and one month of employment, she met Guadalcanal Taka of Takeshi's Army, and they got married just four months after their first meeting, following only three dates. Currently, she is active as a talent in a wide range of fields including television, radio, and magazines, and also delivers the latest health and beauty-related information as an AGELESS navigator.
Opening remarks: A meaningful step towards the future
The event was emceed by Shiho Hashimoto, editor-in-chief of the advanced medical web magazine "Sante" and also a television personality. Her warm and calm demeanor heightened the participants' expectations. In his opening remarks, Shinji Yamanouchi, President and CEO of Well Medical Group Co., Ltd., spoke about "the innovation that regenerative medicine brings to the medical field and its power to open up the future for patients," presenting a grand vision to the participants.
Sharing of insights by distinguished speakers
The event's central lecture sessions featured speakers at the forefront of regenerative medicine. Their detailed presentations on research findings and future prospects in their respective fields impressed many participants.
Yoshitaka Fukuzawa, Professor Emeritus, Aichi Medical University
Dr. [Name missing] is a board member and professor emeritus at Aichi Medical University; he is in charge of the Center for Proactive and Integrative Medicine and the Department of Hepatobiliary and Pancreatic Medicine, and holds a PhD in Medicine. He serves as the chairman of the Japan Society for Proactive Clinical Medicine (JSPCM), the Society for Clinical Genomic Medicine (SOCGM), the Japan Society for Advanced Medical Clinical Research (JSCFS), and a board member of the World Federation of Medical Societies (WFCMS), among other important positions in various academic societies. He has been selected as one of the Best Doctors in Japan six times. He is a Senior Member (FACP) of the American College of Physicians. He is also the chief academic advisor to Clinic 9ru and Prevention Clinic (VIP Health Checkup Center).
1.The future and prospects of regenerative medicine
As an expert in genomic medicine and preventive medicine, Professor Fukuzawa explained how cutting-edge medical treatments contribute to patients' health. In particular, he discussed how personalized medicine will develop, using concrete examples of genomic research in hepatobiliary and pancreatic medicine. Furthermore, as a leading medical scientist in Japan, he clearly outlined future challenges and the path toward their resolution.
Part of the lecture content:
- Evolution of genome analysis technology and its clinical applications
- Proactive healthcare initiatives in Japan and around the world
- Introduction of success stories based on specific patient cases
Yasufumi Murakami, Professor Emeritus, Tokyo University of Science
Professor Emeritus, Tokyo University of Science. Specializes in drug discovery science, molecular biology, and immunology. Completed doctoral studies at the Graduate School of Pharmaceutical Sciences, University of Tokyo. After working at Alberta Einstein College of Medicine, Memorial Sloan Kettering Cancer Center, and RIKEN, he became a professor in the Department of Biotechnology, Faculty of Engineering, Tokyo University of Science. Since his research on tumor viruses at Memorial Sloan Kettering Cancer Center, he has consistently conducted research and development on therapeutic target molecules, antibody production methods, and antibody drugs. He has a world-leading track record in the fields of diagnostic and therapeutic antibodies. Appointed as Chief Research Advisor, SCCL.
2.The forefront of genome research and clinical applications
Next to take the stage was Professor Yasufumi Murakami, a leading expert in drug discovery science and oncology research. He spoke particularly about innovations in antibody drugs and the current state of biomarker development, leaving the participants amazed by the dramatic advancements in medical technology. He also provided a detailed explanation of new approaches to cancer diagnosis, which was highly praised by healthcare professionals.
Part of the lecture content:
- Potential of biomarkers in cancer diagnosis
- New antibody production technologies and the search for therapeutic targets
- Results of collaborative research with the National Cancer Center
Japan Advanced Medical Clinical Research Association, Heidai Kobayashi
He is the Chairman of the Board of Directors of the Japan Advanced Medical Clinical Research Association and a Director and Secretary-General of the International Society for Integrative Medicine. As Secretary-General of the Association of Integrative Medicine Physicians, he has led many cancer and intractable disease patients to healing. He has established numerous organizations, including the NPO Integrative Medicine Health Promotion Association, the Japan Advanced Medical Clinical Research Association, the Cancer and Intractable Disease Zero Association, and the Japan Society for Proactive Clinical Medicine, and works to promote preventive medicine, proactive medicine, and integrative medicine in order to help cancer and intractable disease refugees.
3.Future prospects from joint research with Well Medical Group
Next to take the stage was Heiji Kobayashi, Chairman of the Japan Advanced Medical Clinical Research Association. Mr. Kobayashi gave a lecture on the future prospects of joint research with the Well Medical Group. He specifically introduced their efforts in clinical research and the application of new technologies in the field of advanced medicine, giving hope and inspiration to many participants.
Key points of the lecture:
- Initiatives and Achievements of the Japan Advanced Medical Clinical Research Association
- The path to clinical application of regenerative medicine technology
- Details of the joint project with Well Medical Group
Tetsunari Tsukada, Chief Director of the Clinic
He has worked in a wide range of fields, from general practice to proactive medicine, including the Department of Thoracic Surgery at Keio University School of Medicine, the Deputy Chief of Thoracic Surgery at Kawasaki Hospital, and at membership-based clinics. Based on the knowledge gained from his extensive experience from the forefront of clinical practice to cutting-edge medical research, he has conceived a state-of-the-art clinic dedicated to anti-aging through advanced medical care, and has been appointed as the Chief Director of Clinic 9ru, Prevention Clinic (VIP Health Checkup Center), and BioStyle Clinic Ginza. He is a graduate of Teikyo University School of Medicine.
4.About next-generation total anti-aging care
Dr. Tsukada gave a lecture on the theme of "Next-Generation Total Aging Care." He introduced anti-aging technologies based on preventive medicine, and provided detailed explanations of the cutting-edge medical treatments offered by Clinic 9ru, particularly stem cell therapy and blood purification therapy. He discussed how individualized treatment plans improve patients' quality of life, which resonated with many in the audience.
Masato Iwata, Representative Director, Dermaroller Japan
Representative Director of Transparence Co., Ltd. A pioneer who created the new skincare concept of microneedling, she has signed an official distribution agreement in Japan with Dermaroller GmbH (Germany), the developer of the derma roller. Pre-orders for the "Derma Roller HC902," the first genuine product of the popular self-care derma roller to arrive in Japan, will begin on February 15, 2023, with sales starting on March 1, 2023.
The Fusion of Cosmetics and Regenerative Medicine: Introducing the Latest Technologies
Dermaroller-based stem cell supernatant delivery technology
In the guest lecture, Masato Iwata of Dermaroller Japan Co., Ltd. introduced the latest device, "Dermaroller," which introduces stem cell supernatant into the dermis. This device is attracting attention as a technology that symbolizes the fusion of cosmetic medicine and regenerative medicine. The mechanism by which microneedling using fine needles promotes skin cell turnover and allows stem cell supernatant to penetrate deep into the skin was explained, attracting the interest of the participants.
Key points for implementation:
- Skin regeneration effect of stem cell supernatant
- The cell turnover-promoting effect obtained by stimulating with fine needles.
- Short recovery time after treatment and immediate cosmetic effects.
Socializing and special gifts at the reception
At the social gathering, speakers and participants deepened their connections in a relaxed atmosphere. It was a forum where they could freely exchange opinions with medical professionals they wouldn't normally have the opportunity to speak with directly, and there was a sense that many new collaborations would emerge.
In addition, special gifts were prepared for all participants. Particularly noteworthy were the "9RU Face Mask" equipped with a next-generation absorption system and the "Exosome Hair Filler" which utilizes NanoPDS technology. These products embody the fusion of beauty and regenerative medicine, and participants expressed their delight.
In conclusion
Through this event, many people were able to share the future possibilities that regenerative medicine and cosmetic medicine can bring. By directly learning about cutting-edge technologies and knowledge, participants took away hope for further advancements in the medical field.
We expect even more cutting-edge technologies and research findings to be presented at the next event. If you are interested in regenerative medicine or cosmetic medicine, please consider attending next time.
Shinji Yamanouchi, Representative Director, Well Medical Group Co., Ltd.
Comment